Episode

The Dark Side of Building a Healthcare System That Works | Ep. 391 with Harry DiFrancesco Founder & CEO of Carda Health

Podcast: Founder's Story
Published: Apr 24, 2026
Duration seconds: 1242
Processing state: not_requested
Canonical source: https://bleav.com/shows/founders-story/episodes/the-preventative-health-crisis-and-the-ai-engine-behind-carda-health-ep-391-with-harry-difrancesco-founder-ceo-of-carda-health/
Audio: https://clrtpod.com/m/pscrb.fm/rss/p/mgln.ai/e/1184/afp-969439-injected.calisto.simplecastaudio.com/a7765f3f-02e4-4ded-bca1-01a20b7f82a5/episodes/3362c495-9784-4cef-ac4e-3a864087dc05/audio/128/default.mp3?aid=rss_feed&awCollectionId=a7765f3f-02e4-4ded-bca1-01a20b7f82a5&awEpisodeId=3362c495-9784-4cef-ac4e-3a864087dc05&feed=NVPdHs07
JSON: /v1/public/podcasts/founder-s-story-648906/episodes/the-dark-side-of-building-a-healthcare-system-that-works-ep-391-with-harry-difrancesco-founder-ceo-of-carda-health
Markdown: /podcast/founder-s-story-648906/the-dark-side-of-building-a-healthcare-system-that-works-ep-391-with-harry-difrancesco-founder-ceo-of-carda-health.md

Actions

POST https://stenobird.com/v1/public/podcasts/founder-s-story-648906/episodes/the-dark-side-of-building-a-healthcare-system-that-works-ep-391-with-harry-difrancesco-founder-ceo-of-carda-health/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/founder-s-story-648906/the-dark-side-of-building-a-healthcare-system-that-works-ep-391-with-harry-difrancesco-founder-ceo-of-carda-health.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Daniel Robbins sits down with Harry DiFrancesco, founder and CEO of Carda Health, to unpack why U.S. healthcare rewards sick care instead of prevention and how Carda is rebuilding recovery at home. Harry shares his personal mission shaped by his father’s heart disease, the shocking stat that 90% of heart patients never access rehab, and how Carda uses AI as an “invisible engine” to unburden clinicians while improving outcomes. They also debate GLP-1s, behavior change, and why building a resilient company feels a lot like running 100 miles.